Genetic Testing

Mayo Clinic Study Uses Phenomix AI Algorithm to Predict GLP-1 Side Effects, Advancing Personalized Obesity Care and Drug DevelopmentMayo Clinic Study Uses Phenomix AI Algorithm to Predict GLP-1 Side Effects, Advancing Personalized Obesity Care and Drug Development

Mayo Clinic Study Uses Phenomix AI Algorithm to Predict GLP-1 Side Effects, Advancing Personalized Obesity Care and Drug Development

Study presented at DDW 2025 finds genetic risk scores can identify patients at higher risk of nausea from GLP-1 therapies,…

2 days ago
A Success Story – DelveInsight’s Strategic Support to a Biopharma Leader in NSCLC Epidemiology Forecasting up to 2034, Segmented by Biomarker TypesA Success Story – DelveInsight’s Strategic Support to a Biopharma Leader in NSCLC Epidemiology Forecasting up to 2034, Segmented by Biomarker Types

A Success Story – DelveInsight’s Strategic Support to a Biopharma Leader in NSCLC Epidemiology Forecasting up to 2034, Segmented by Biomarker Types

In the rapidly evolving landscape of oncology, precision is the cornerstone of progress. A leading biopharmaceutical company specializing in non-small…

2 weeks ago
The Love for Liam Foundation to Host the Fourth Annual Liam Johnson Memorial Golf Outing & Benefit Dinner on May 2, 2025The Love for Liam Foundation to Host the Fourth Annual Liam Johnson Memorial Golf Outing & Benefit Dinner on May 2, 2025

The Love for Liam Foundation to Host the Fourth Annual Liam Johnson Memorial Golf Outing & Benefit Dinner on May 2, 2025

PHILADELPHIA, April 24, 2025 (GLOBE NEWSWIRE) -- The Love for Liam Foundation, a 501(c)(3) nonprofit that seeks to raise awareness…

2 weeks ago
Avalon Healthcare Solutions Secures Patent for Groundbreaking Lab Claims Review TechnologyAvalon Healthcare Solutions Secures Patent for Groundbreaking Lab Claims Review Technology

Avalon Healthcare Solutions Secures Patent for Groundbreaking Lab Claims Review Technology

APEA platform recognized for transforming real-time policy enforcement and powering smarter diagnostics decisions TAMPA, Fla., April 16, 2025 /PRNewswire/ --…

3 weeks ago
Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based SolutionsCepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions

Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions

Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases…

1 month ago
Children’s Hospital Colorado Announces Innovative In-House Whole-Genome Sequencing LabChildren’s Hospital Colorado Announces Innovative In-House Whole-Genome Sequencing Lab

Children’s Hospital Colorado Announces Innovative In-House Whole-Genome Sequencing Lab

Setting the standard through dynamic genomic technology platform, improving patient outcomes AURORA, Colo., March 12, 2025 /PRNewswire/ -- The Children's…

2 months ago
Children’s Hospital Colorado Announces Innovative In-House Whole-Genome Sequencing LabChildren’s Hospital Colorado Announces Innovative In-House Whole-Genome Sequencing Lab

Children’s Hospital Colorado Announces Innovative In-House Whole-Genome Sequencing Lab

Setting the standard through dynamic genomic technology platform, improving patient outcomes AURORA, Colo., March 12, 2025 /PRNewswire/ -- The Children's…

2 months ago
Corvus Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial of Soquelitinib for Patients with Autoimmune Lymphoproliferative Syndrome (ALPS)Corvus Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial of Soquelitinib for Patients with Autoimmune Lymphoproliferative Syndrome (ALPS)

Corvus Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial of Soquelitinib for Patients with Autoimmune Lymphoproliferative Syndrome (ALPS)

Trial for this rare genetic disease to be conducted by NIH/NIAID in partnership with Corvus ITK inhibition intended to address…

2 months ago
FACIT and OBIO® announce inaugural WeSEED cohort of women-led start-ups in joint seed capital and commercialization programFACIT and OBIO® announce inaugural WeSEED cohort of women-led start-ups in joint seed capital and commercialization program

FACIT and OBIO® announce inaugural WeSEED cohort of women-led start-ups in joint seed capital and commercialization program

Program supports women entrepreneurs in life science who are driving the advancement of innovations and healthcare TORONTO, March 6, 2025…

2 months ago
Visionary Holdings: Generative AI Leads the Efficiency Revolution, Reshaping the Future of FinTech and BiotechnologyVisionary Holdings: Generative AI Leads the Efficiency Revolution, Reshaping the Future of FinTech and Biotechnology

Visionary Holdings: Generative AI Leads the Efficiency Revolution, Reshaping the Future of FinTech and Biotechnology

TORONTO, Feb. 28, 2025 /PRNewswire/ -- In the context of the global economy's digital transformation, Artificial Intelligence (AI) has emerged…

2 months ago